Skip to main content
OpenTrials

Clinical trial condition

Hodgkin Disease

Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.

958 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Hodgkin Disease trial results

Completed

Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)

NCT02939014

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Sun Yat-san University Cancer Center Guangzhou, Guangdong, China
  • Jiangsu Cancer Hospital Nanjing, Jiangsu, China
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease.

NCT02227433

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • ASST Spedali Civili di Brescia Brescia, BS, Italy
  • Irccs Centro Di Riferimento Oncologico Di Aviano (Pn) Aviano, Italia, Italy
  • Policlinico S.Orsola Malpighi Bologna, Italy
  • Irccs Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale Di Napoli Naples, Italy
View Trial Details
Completed

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

NCT00670592

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • St. Francis Cancer Research Foundation Dept.ofSt.FrancisCancerRes.(2) Beech Grove, Indiana, United States
  • Dana Farber Cancer Institute SC-5 Boston, Massachusetts, United States
  • Wake Forest University Baptist Medical Center Dept. of Industry Research (2) Winston-Salem, North Carolina, United States
View all 28 locations
View Trial Details

Related conditions